Article
Monckeberg's calciphylaxis with necrosis of the glans penis: a case presentation.
Department of Urology, University of Washington School of Medicine, Harborview Medical Center, Seattle, WA 98105, USA.
Hemodialysis International (impact factor:
1.54).
08/2007;
11(3):300-2.
DOI:10.1111/j.1542-4758.2007.00183.x
pp.300-2
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease.
[show abstract] [hide abstract]
ABSTRACT: Autopsy studies have demonstrated the near universal presence of fatty streaks and fibroatheromas in the general population from which patients with chronic kidney disease (CKD) arise. The vast majority of patients with CKD have multiple conventional cardiovascular risk factors. Vascular atherosclerotic calcification develops in most patients as they transition from the general population to significant CKD as part of cholesterol crystallization within atherosclerotic lesions. Once present, however, atherosclerotic medial calcification can become prominent and has been previously identified as Mönckeberg's sclerosis. A unifying concept supported by the preponderance of pathologic evidence contends that Mönckeberg's sclerosis is a manifestation of accelerated atherosclerosis in patients with CKD. The term has also been used in rare cases to describe vascular calcinosis not related to CKD. This clarification is critical to advance the field in terms of pathologic diagnosis and treatment of CKD bone and mineral disorder. Factors that seem to promote the osteoblastic transformation of vascular smooth muscle cells and enhance deposition of calcium hydroxyapatite crystals include phosphorus activation of the Pit-1 receptor, bone morphogenic proteins 2 and 4, leptin, endogenous 1,25 dihydroxyvitamin D, vascular calcification activating factor, and measures of oxidative stress. These entities work to accelerate the atherosclerotic process in patients with CKD and may be future targets for diagnosis and treatment because randomized trials with hydroxymethylglutaryl-CoA reductase inhibitors have failed to attenuate the rate of progressive vascular calcification.Clinical Journal of the American Society of Nephrology 08/2008; 3(6):1585-98. · 5.23 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
6 years
65-year-old man
complete penectomy
end-stage renal disease
ESRD
four extremities
glans penis
Harborview Medical Center
life-threatening condition
medical management
Monckeberg's calcific sclerosis
Pathologic evaluation
patients
Penile gangrene
penile vessels
progressed
proximal corpora cavernosa
severe penile pain
spongiosum